Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
vc
2
×
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
biotech
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
crispr
david walt
deals
deerfield management
detroit blog main
detroit top stories
diagnostics
drug development
drug discovery
esperion
europe blog main
europe top stories
fda
feng zhang
financing
What
bio
2
×
medicines
2
×
activity
approvals
biogen
clamped
covid
create
crispr
delays
developing
diagnostic
diseases
economic
editing
fast
fda
fix
gene
heats
high
human
including
ipo
isn’t
launches
lot
new
oric’s
race
roundup
sherlock
showing
spread
stakes
technology
testing
trials
underway
use
Language
unset
Current search:
vc
×
medicines
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M